The Idera Pharmaceuticals Inc (NASDAQ:IDRA) On Mar. 13 reported its financial and operational results for the fourth quarter and year ended December 31, 2013. Net loss applicable to common stockholders for the three months ended December 31, 2013 was $6.4 million, or $0.10 per diluted share, compared to a net loss applicable to common stockholders of $6.5 million, or $0.24 per diluted share, for the same period in 2012. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock opened today at $6.80 and is currently trading at $6.62. The stock showed a positive weekly performance of 14.41%.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc. (NASDAQ:GALE) securities between November 6, 2013 and February 14, 2014. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $2.90, in current trading session and currently is at $2.96, by gaining 4.93%.The 52 week range of $1.65-$7.77.Company’s market capitalization is $311.50 million.
EXACT Sciences Corp. (NASDAQ:EXAS) was the target of some unusual options trading on Monday. Investors acquired 4,782 put options on the company, Analyst Ratings.Net reports. This represents an increase of approximately 523% compared to the typical volume of 767 put options. EXACT Sciences Corporation (NASDAQ:EXAS) stock is currently trading at $15.06 .The EPS of the stock is -0.69. Company’s market capitalization is $1.07 billion.
Horizon Pharma Inc. (NASDAQ:HZNP) announced Wednesday morning that it agreed to acquire Vidara Therapeutics International Ltd. through a reverse merger for stock and cash valued at approximately $660 million. Pharma Inc (NASDAQ:HZN) stock opened the session at $18.00, and now is at $16.93. The 52 week range of the HZN stock remained $2.11-$18.30 and the day range was $16.43-$18.30.